AHR and urinary bladder carcinoma: Further investigation is warranted to elucidate how AhR signaling regulates the expression or activity of FADS1 and FADS2 in bladder cancer, which may help uncover the mechanisms underlying the altered MUFA/PUFA ratio observed in our study.